We are live on ! Find out more
Principal Financial Group

Principal Financial Group Portfolio holdings

AUM $204B
1-Year Est. Return 27.99%
 

Principal Financial Group, founded in 1879 as the Bankers Life Association by Edward Temple and headquartered in Des Moines, Iowa, is a global financial services firm specializing in retirement solutions, insurance, and asset management, overseeing more than $709 billion in assets under management as of late 2024. Serving over 62 million customers across individuals, businesses, and institutions, Principal offers 401(k) plans, group insurance (life, disability, dental), annuities, and investment products through its Principal Global Investors arm, with a strong focus on U.S. and international markets like Asia and Latin America. Known for its stability and customer-centric approach, the publicly traded company (NASDAQ: PFG) under CEO Dan Houston has expanded through acquisitions like Wells Fargo’s retirement business in 2019, emphasizing long-term financial security. With a workforce of over 19,000 and a legacy of resilience, Principal remains a trusted name in retirement and wealth management.

This Fund
S&P 500
This Quarter Est. Return
+0.83%
1 Year Est. Return
+27.99%
3 Year Est. Return
+94.11%
5 Year Est. Return
+116.64%
10 Year Est. Return
+475.57%
AUM
$153B
AUM Growth
-$1.43B
Cap. Flow
-$1.33B
Cap. Flow %
-0.87%
Top 10 Hldgs %
14.38%
Holding
2,664
New
68
Increased
1,034
Reduced
1,458
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 19.12%
2 Real Estate 16.4%
3 Financials 14.67%
4 Consumer Discretionary 12.1%
5 Healthcare 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRRX
2526
DELISTED
DURECT Corp
DRRX
$63K ﹤0.01%
4,926
+1,309
+36% +$17.8K
LITS
2527
Lite Strategy Inc
LITS
$32.5M
$63K ﹤0.01%
1,147
+306
+36% +$16.8K
TRVN
2528
DELISTED
Trevena, Inc.
TRVN
$63K ﹤0.01%
82
-12
-13% -$10.2K
HGEN
2529
DELISTED
HUMANIGEN, INC.
HGEN
$63K ﹤0.01%
10,624
-1,723
-14% -$24.2K
FLXN
2530
DELISTED
Flexion Therapeutics, Inc.
FLXN
$63K ﹤0.01%
10,400
-985
-9% -$6.14K
STXS icon
2531
Stereotaxis
STXS
$138M
$57K ﹤0.01%
+10,627
New +$80.1K
TNXP icon
2532
Tonix Pharmaceuticals
TNXP
$179M
0
SYRS
2533
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$55K ﹤0.01%
1,224
-199
-14% -$9.71K
ATHX
2534
DELISTED
Athersys, Inc. Common Stock
ATHX
$54K ﹤0.01%
1,627
+391
+32% +$14.9K
SLDB icon
2535
Solid Biosciences
SLDB
$859M
$52K ﹤0.01%
1,459
-236
-14% -$10K
ORC
2536
Orchid Island Capital
ORC
$1.28B
$51K ﹤0.01%
2,087
-102
-5% -$2.57K
AWH
2537
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$51K ﹤0.01%
1,047
+272
+35% +$16.8K
CBAY
2538
DELISTED
Cymabay Therapeutics
CBAY
$50K ﹤0.01%
13,684
-2,219
-14% -$8.74K
FBIO icon
2539
Fortress Biotech
FBIO
$92.7M
$49K ﹤0.01%
1,012
+264
+35% +$12.9K
XPRO icon
2540
Expro Ltd
XPRO
$1.83B
$49K ﹤0.01%
2,771
-599
-18% -$10.2K
ARDX icon
2541
Ardelyx
ARDX
$1.21B
$43K ﹤0.01%
32,636
-817
-2% -$2.18K
ADVM
2542
DELISTED
Adverum Biotechnologies
ADVM
$42K ﹤0.01%
1,936
-1,317
-40% -$33.6K
OVID icon
2543
Ovid Therapeutics
OVID
$489M
$42K ﹤0.01%
12,598
-2,043
-14% -$7.45K
LTRPA
2544
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$42K ﹤0.01%
13,542
+2,631
+24% +$9.79K
OTLK icon
2545
Outlook Therapeutics
OTLK
$193M
$41K ﹤0.01%
951
+251
+36% +$12.1K
QTNT
2546
DELISTED
Quotient Limited Ordinary Shares
QTNT
$41K ﹤0.01%
434
+108
+33% +$13.5K
IMDX
2547
Insight Molecular Diagnostics
IMDX
$161M
$38K ﹤0.01%
534
-6,221
-92% -$572K
ATOS icon
2548
Atossa Therapeutics
ATOS
$23.8M
$35K ﹤0.01%
717
-207
-22% -$12K
GERN icon
2549
Geron
GERN
$1.05B
$35K ﹤0.01%
25,422
-9,376
-27% -$12.5K
TYME
2550
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$35K ﹤0.01%
33,858
-5,486
-14% -$6.04K

Similar funds

Principal Financial Group's Q3 2021 Portfolio in Review

As of Q3 2021, Principal Financial Group held 2,664 positions worth $153B, down 0.92% from $155B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Principal Financial Group's Q3 2021 filing shows 68 new, 1,034 increased, 1,458 reduced and 90 closed positions. Its largest new stake was Core & Main: 1,236,704 shares worth $32.4M. The largest sale was Welltower, an estimated $725M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Real Estate and Financials.

  • Principal Financial Group's largest Q3 2021 buy was Core & Main: 1,236,704 shares worth $32.4M.
  • Principal Financial Group added most to Ventas in Q3 2021, an estimated $616M increase.
  • Principal Financial Group's biggest Q3 2021 reduction was Welltower, cutting an estimated $725M.
  • Principal Financial Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $52.5M.
  • Principal Financial Group's ten largest holdings make up 14% of its $153B portfolio in Q3 2021.
  • Principal Financial Group opened 68 new positions and closed 90 in Q3 2021.
  • Principal Financial Group's portfolio value fell 0.92% quarter-over-quarter to $153B.

Based on Principal Financial Group's 13F filing for Q3 2021, filed 9 Nov 2021.